MICROBOT MEDICAL INC.

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

02 Jun 2023 12:36:53 By Nasdaq GlobeNewswire

Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System

02 Jun 2023 08:16:15 By Nasdaq GlobeNewswire

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

31 May 2023 08:30:00 By Nasdaq GlobeNewswire

Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic System’s First Human Trial

25 May 2023 08:40:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

24 May 2023 13:05:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 May 2023 15:24:08 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

23 May 2023 13:41:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

22 May 2023 15:18:00 By Nasdaq GlobeNewswire

Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians

22 May 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases

18 May 2023 09:15:00 By Nasdaq GlobeNewswire

Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System

08 May 2023 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Final Data From Its Recent Animal Study

05 May 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical’s LIBERTY® Robotic System Surpasses 100th Catheterization

03 May 2023 09:00:01 By Nasdaq GlobeNewswire

Gerry O’Sullivan, the Latest Member to Join Microbot Medical’s Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases

23 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to Accelerate

16 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board

13 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical’s Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference

09 Mar 2023 09:00:01 By Nasdaq GlobeNewswire

Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System

02 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting

28 Feb 2023 09:00:01 By Nasdaq GlobeNewswire

Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board

27 Feb 2023 09:00:00 By Nasdaq GlobeNewswire